Fig. 1.

Timelines of progression of the clinical courses of the 2 patients with confirmed SARS-CoV-2 infection. Red boxes show the events for patient 1 and green boxes show the events for patient 2. ABL, amphotericin B liposomal; ARDS, acute respiratory distress syndrome; CT, computed tomography; ED, emergency department; FiO₂, fraction of inspired oxygen; HCQ, hydroxychloroquine; LMWH, low-molecular-weight heparin; Lop/R, lopinavir/ritonavir; MPS, methylprednisolone; MSSA, methicillin-sensitive Staphylococcus aureus; MV, mechanical ventilation; OS, oxygen saturation; PE, pulmonary embolism; q.i.d., 4 times a day; QTc, corrected QT interval; TC, tocilizumab.